Intellectual Property

  • April 07, 2025

    Jaguar Land Rover Inks Patent License Deal With Avanci

    Avanci and British automotive manufacturer Jaguar Land Rover have struck a deal over a pool of essential patents linked to 5G connected vehicles, the U.S. license operator announced Monday.

  • April 07, 2025

    Denver Builder Says Ex-Employee Stole Info For Competitor

    A full-service general building contractor has accused a former employee and an industry rival in Colorado state court of using stolen confidential business information to make a competitive bid for a 2025 "large scale" Colorado project that's anticipated to create more than $20 million in revenue.

  • April 07, 2025

    Atty For Artist In Copyright AI Suit Asks To Exit Case

    An attorney for a Colorado artist who sued the U.S. Copyright Office over its rejection of his application to register his artificial intelligence-generated work is asking to withdraw from the case, saying her client hasn't been able to pay all of his legal bills.

  • April 07, 2025

    DraftKings Eyes 3rd Circ. Review Of MLB Players' Suit Claims

    DraftKings has asked a Pennsylvania federal court to allow the Third Circuit to weigh in on key unsettled legal issues in a lawsuit that accuses the organization of using the photos of MLB players without permission, saying a decision in its favor could end the case.

  • April 08, 2025

    Justices Skip Fruit Art, Abandoned TM And Sentence Petitions

    The U.S. Supreme Court on Monday declined petitions regarding the standard for considering whether unregistered trademarks are abandoned in a case involving T-Mobile, a copyright dispute over fruit taped to walls as part of an art installation, and sentencing guidelines in the theft of trade secrets belonging to General Electric.

  • April 04, 2025

    AbbVie Says Aurobindo's Rinvoq Generic Infringes Patent

    AbbVie on Friday launched a patent infringement lawsuit in Delaware federal court over Aurobindo Pharma's tentatively approved generic version of the blockbuster immunosuppressant Rinvoq, the latest in a series of intellectual property litigation over the treatment.

  • April 04, 2025

    Nokia Reaches Deal Before EDTX Patent Trial, T-Mobile Still On

    Nokia has settled out of a lawsuit accusing its equipment customer, T-Mobile, of infringing a Dallas-based patent business' wireless communications patents, according to a settlement notice filed Friday in Texas federal court, leaving T-Mobile and its other network equipment supplier, Ericsson, to face trial April 5.

  • April 04, 2025

    Toyota Wins Patent Case Against UNM In Texas Court

    A Texas federal court has shot down a lawsuit against Toyota Motor North America Inc. over a University of New Mexico wireless communications patent after finding that the Federal Circuit already invalidated "the sole claim ever asserted in this case."

  • April 04, 2025

    11th Circ. Revives Aircraft Co.'s Deal Suit Against Boeing

    The Eleventh Circuit on Friday revived a defunct aircraft maintenance company's trade secret case against Boeing amid a long-running contract dispute and allowed the company to pursue damages for unjust enrichment after finding it wouldn't be duplicative of the $2.1 million jury award it won at trial in 2020 for its breach of contract claims.

  • April 04, 2025

    Judge Details Preserving IP Claims Against Microsoft, OpenAI

    A New York federal judge on Friday explained a decision from March that kept intact news organizations' direct and contributory copyright infringement claims accusing Microsoft and OpenAI of copying their content to train generative artificial intelligence models.

  • April 04, 2025

    Inventor Gets Chance To Clear Up Infrared Detector IP Suit

    A Court of Federal Claims judge has found that an inventor's claims that the federal government infringed or authorized the infringement of infrared detector patents aren't sufficient at this point but gave him the opportunity to amend his case.

  • April 04, 2025

    Texas Justices Deny UnitedHealthcare, Humana Records Row

    The Texas Supreme Court declined Friday to take up a dispute between United HealthCare Services Inc. and Humana Insurance Co. over whether UnitedHealthcare should have to turn over Medicare documents connected to a state retirement plan.

  • April 04, 2025

    Fed. Circ. Says AMS' $48M Trade Secrets Win Needs More Math

    The Federal Circuit ruled Friday that a Texas federal court will need to take yet another look at the prejudgment interest calculation in a $48 million-plus judgment in a trade secrets case between chipmakers AMS and Renesas over stolen light sensor technology that has been in the courts for nearly two decades.

  • April 04, 2025

    Perplexity AI Tries To Cancel TM In Software Co. IP Fight

    Perplexity AI Inc. has launched its counteroffensive against a California federal court suit accusing it of trademark infringement by asking the court to cancel the trademark at the heart of the case brought earlier this year by a software company.

  • April 04, 2025

    UK Litigation Roundup: Here's What You Missed In London

    This past week in London has seen Russian industrialist Oleg Deripaska target the intelligence arm of CT Group with a commercial fraud claim, Big Technologies sue its former CEO for allegedly concealing interests in several shareholders, and an investment firm tackle a professional negligence claim by Adidas. Here, Law360 looks at these and other new claims in the U.K.

  • April 04, 2025

    Off The Bench: City Sues Sportsbooks, Ex-NFLer Battles TMZ

    In this week's Off The Bench, Baltimore joins the fight against promotional tactics by DraftKings and FanDuel, Terrell Owens tries to protect a catchphrase in a trademark suit, and a trial over a child's injuries at a golf facility draws closer.

  • April 04, 2025

    Westlaw Rival Gets Early Appeal Of 1st Fair Use AI Ruling

    The Third Circuit will be the first appeals court to weigh in on a dispute over using copyrighted material to train artificial intelligence systems after a Delaware federal court on Friday granted permission to send up questions from ROSS Intelligence Inc. over the copyrightability of Thomson Reuters' Westlaw headnotes and fair use.

  • April 03, 2025

    GSK, Pfizer Agree To End Patent Fight Over RSV Vaccines

    British pharmaceutical company GlaxoSmithKline PLC and New York-based Pfizer Inc. on Thursday agreed to end their legal fight over Pfizer's respiratory syncytial virus vaccine Abrysvo that allegedly infringed GSK patents that Pfizer had countered were invalid or unenforceable.

  • April 03, 2025

    NC Biz Court Trims Semiconductor Co.'s Trade Secrets Suit

    A North Carolina Business Court judge has permitted the majority of a silicon carbide technology company's suit to proceed against two former executives and the competitor they allegedly helped unfairly compete against it, preserving its claims that they took off with trade secrets.

  • April 03, 2025

    Alsup Calls Out Anthropic Over Missed Discovery Deadlines

    U.S. District Judge William Alsup scolded Anthropic for again delaying discovery production in a proposed class action accusing the artificial intelligence startup of exploiting the copyrighted works of journalists and authors to train its large language model.

  • April 03, 2025

    Website, Licensing Co. Settle Food Photo Copyright Suit

    The owner of a Las Vegas-based promotional website has agreed to settle its copyright dispute with a food photo licensing company that was previously criticized for so-called "copyright trolling."

  • April 03, 2025

    International Disputes And Trade Lawyer Heads To Foley Hoag

    A trade lawyer with experience in World Trade Organization dispute settlement and commercial mediation has joined Foley Hoag LLP's international litigation and arbitration practice in Paris as senior counsel, according to the law firm.

  • April 03, 2025

    Photographer Wants Justices To Look At 'Server Test'

    A Los Angeles-based photographer has urged the U.S. Supreme Court to review his failed lawsuit against a travel website over embedding Instagram posts, challenging the Ninth Circuit's "server test" for determining liability for online copyright infringement claims.

  • April 03, 2025

    JPML Steers Pretrial Matters In OpenAI Copyright Fight To NY

    The Judicial Panel on Multidistrict Litigation on Thursday decided to centralize the pretrial work for a series of copyright infringement and Digital Millennium Copyright Act lawsuits against OpenAI in New York federal court.

  • April 03, 2025

    Senate Panel Advances Bills Tackling Drug Patents, Pricing

    A U.S. Senate panel on Thursday approved a group of bills tackling pharmaceutical patents and drug pricing, including measures that claim to address so-called patent thickets and an industry practice called "product hopping."

Expert Analysis

  • 4 Trade Secret Developments To Follow This Year

    Author Photo

    Significant developments in trade secret law are likely in 2025, and areas to watch include protection of AI-related innovations, the fate of the Federal Trade Commission's noncompete ban, and questions of the federal Defend Trade Secrets Act's extraterritorial reach, say attorneys at Faegre Drinker.

  • Republican Trifecta Amplifies Risks For Cos. In 3 Key Areas

    Author Photo

    Expected coordination between a Republican Congress and presidential administration may expose companies to simultaneous criminal, civil and congressional investigations, particularly with regard to supply chain risks in certain industries, government contracting and cross-border investment, say attorneys at Morgan Lewis.

  • New Law In NY Places Employee NIL Rights In Spotlight

    Author Photo

    New York recently became the first state to codify name, image and likeness rights for models, but as such protections seemingly expand for individual employees across industries, employers may want to brush up on related case law, and update their handbooks and policies accordingly, says Timothy Bechen at Woods Rogers.

  • Penn State Brand Case Leaves Ornamentality Unresolved

    Author Photo

    While the recent jury verdict in Penn State University v. Vintage Brand was a win for the college and brands, legal practitioners should expect plenty of litigation around unaddressed ornamentality issues of whether marks that are not yet incontestable can be canceled for being used solely in decorative, non-source-identifying ways, say attorneys at Debevoise.

  • Defense Strategies For Addressing Conspiracy-Minded Jurors

    Author Photo

    As conspiracy theories continue to proliferate and gain traction in the U.S., defense attorneys will need to consider ways to keep conspiracy-minded jurors from sitting on the jury, and to persuade them when this isn’t possible, say consultants at IMS Legal Strategies.

  • 7 Ways 2nd Trump Administration May Affect Partner Hiring

    Author Photo

    President-elect Donald Trump's return to the White House will likely have a number of downstream effects on partner hiring in the legal industry, from accelerated hiring timelines to increased vetting of prospective employees, say recruiters at Macrae.

  • Reviewing 2024's AI Patent And Copyright Developments

    Author Photo

    Attorneys at Rothwell Figg provide highlights on procedural and substantive intellectual property issues pertaining to AI in 2024 from the Copyright Office and U.S. Patent and Trademark Office, followed by what to expect in 2025.

  • Trump, Tariffs And Tech: The Right To Repair In 2025

    Author Photo

    The "right-to-repair" movement has helped make it easier for independent repair shops and consumers to repair their devices and vehicles — but President-elect Donald Trump's complicated relationship with Big Tech, and his advocacy for increased tariffs, make the immediate future of the movement uncertain, say attorneys at Carter Ledyard.

  • E-Discovery Quarterly: Rulings On Custodian Selection

    Author Photo

    Several recent rulings make clear that the proportionality of additional proposed custodians will depend on whether the custodians have unique relevant documents, and producing parties should consider whether information already in the record will show that they have relevant documents that otherwise might not be produced, say attorneys at Sidley.

  • Fed. Circ. Patent Decisions In 2024: An Empirical Review

    Author Photo

    Despite an ever-increasing backlog of argument-ready cases, the Federal Circuit issued fewer decisions in 2024 than in previous years, and the decisions' overall friendliness toward patent owners and applicants was low, says Dan Bagatell at Perkins Coie.

  • What To Expect In Higher Ed Enforcement Under Trump

    Author Photo

    Colleges and universities should prepare for shifting priorities, as President-elect Donald Trump is likely to focus less on antitrust cases and more on foreign relations policy, while congressional oversight of higher education continues to increase, say attorneys at Steptoe.

  • How Trial Attys Can Wield Amended Federal Evidence Rules

    Author Photo

    Trial lawyers should assess recent amendments to four Federal Rules of Evidence and a newly enacted rule on illustrative aids to determine how to best use the rules to enhance pretrial discovery and trial strategy, says Stewart Edelstein, former litigation chair at Cohen & Wolf.

  • Series

    Exercising On My Peloton Bike Makes Me A Better Lawyer

    Author Photo

    While I originally came to the Peloton bike for exercise, one cycling instructor’s teachings have come to serve as a road map for practicing law thoughtfully and mindfully, which has opened opportunities for growth and change in my career, says Andrea Kirshenbaum at Littler.

  • 5 Drug And Device Developments That Shaped 2024

    Author Photo

    The last year saw significant legal developments affecting drug and device manufacturers, with landmark decisions and regulatory changes that require vigilance and agility from the industry, say attorneys at Faegre Drinker.

  • Rejoinder Strategy After Allergan Double-Patenting Case

    Author Photo

    A closer look at last year's Allergan v. MSN case at the Federal Circuit highlights the importance of rejoinder during patent prosecution in view of the risks associated with obviousness-type double patenting based on later-filed applications in the same patent family, say attorneys at BCLP.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!